Solidsoft Reply Successfully Migrates Estonia’s National Medicines Verification System to SafeNationVS
Solidsoft Reply, a Reply Group company specialising in Microsoft Azure cloud-based enterprise solutions, has successfully migrated Estonia’s National Medicines Verification System (REKS) to Solidsoft Reply’s proprietary National Blueprint Solution, SafeNationVS.
The completed project marks yet another successful largescale system migration, following Solidsoft Reply’s FiMVO migration in 2023. This underscores Estonia’s ongoing commitment to patient safety and pharmaceutical transparency. As part of the European Medicines Verification System (EMVS), REKS ensures that all prescription medicines dispensed across Estonia are genuine and compliant with EU Falsified Medicines Directive (FMD) standards.
The 6-month project successfully migrated over 6 years' worth of medicinal data, millions of medicines pack records, while establishing connections with key stakeholders across the pharmaceutical supply chain.
This highly complex migration was delivered in close collaboration with REKS and required workshops for Estonian IT suppliers, modifications of a fully validated migration toolset, and documentation on how data is transitioned. This ensured a secure and seamless transition to Solidsoft's leading national blueprint system with full traceability of its data for auditing purposes.
Raul Mill, General Manager of REKS (Ravimite Elektrooniline Kontrollsüsteem), remarked:
"The migration of a national system like REKS is a critical operation and the contribution of all REKS partners is essential. Of particular note is the contribution of Solidsoft Reply in managing this process. Their expertise, clarity, and collaborative mindset helped us meet our timelines with confidence. The result is not only a modernised infrastructure, but a secure, reliable platform that enhances Estonia’s medicines verification system.”
David Eccles, Partner at Solidsoft Reply, added:
“This migration showcases the robustness of our SafeNationVS solution and the exceptional service capability of the Solidsoft team. Six months ago, I committed to the Estonian (REKS) board of directors in Tallinn that the migration would be 'Safe in Our Hands,' and I am pleased to confirm that we have fulfilled this promise”
With this migration, Estonia joins a growing network of 15 other fully operational and secure National Medicine Verification System (NMVS) platforms across Europe, powered by Solidsoft Reply. This milestone reinforces Solidsoft Reply’s expertise in launching and migrating healthcare systems across Europe to improve patient safety, ensure regulatory adherence, and optimise the efficiency of pharmaceutical supply chains.
REKS
REKS is a non-profit organisation established to manage and coordinate the Estonian Medicine Verification System. The purpose of REKS is to ensure that genuine medicinal products can pass through the legal supply chain of medicinal products which can be technically verified.
Solidsoft Reply
Solidsoft Reply is a leading technology company creating award-winning solutions utilising the Microsoft Azure cloud platform. As a globally acclaimed Microsoft AI Cloud Solutions Partner, we specialise in GS1 traceability systems worldwide, crucially ensuring the authenticity, legality, and safety of our customers’ products and services. Serving non-profits, NGOs, healthcare, and the pharmaceutical industries, we deliver technology for positive social impact. Your products, safe in our hands.
Reply
Reply [EXM, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply supports major industrial groups in the telecom and media; industry and services; banking and insurance and public sectors in defining and developing business models enabled by the new paradigms of AI, cloud computing, digital media and the internet of things. Reply's services include: consulting, system integration and digital services. www.reply.com